Thomas ChmielewskiDirector, Disclosure, Transparency
Tom Chmielewski is the Director of Disclosure & Transparency at Jazz Pharmaceuticals, where he oversees Jazz’s global portfolio of protocol registrations, summary results, and clinical transparency deliverables. Tom has 10 years of progressive experience in the biopharmaceutical industry, with past experience ranging from leading data sharing implementation at a large pharmaceutical company, to helping to create the Disclosure & Transparency function at a small biotech.
Tom graduated from Rutgers University and holds a JD from Rutgers Law School. In his free time, he enjoys playing golf and exploring Philadelphia, PA, where he lives.